Literature DB >> 23357734

Cytoplasmic tails of bunyavirus Gn glycoproteins-Could they act as matrix protein surrogates?

Tomas Strandin1, Jussi Hepojoki, Antti Vaheri.   

Abstract

Viruses of the family Bunyaviridae are negative-sense RNA viruses (NRVs). Unlike other NRVs bunyaviruses do not possess a matrix protein, which typically facilitates virus release from host cells and acts as an anchor between the viral membrane and its genetic core. Therefore the functions of matrix protein in bunyaviruses need to be executed by other viral proteins. In fact, the cytoplasmic tail of glycoprotein Gn (Gn-CT) of various bunyaviruses interacts with the genetic core (nucleocapsid protein and/or genomic RNA). In addition the Gn-CT of phleboviruses (a genus in the family Bunyaviridae) has been demonstrated to be essential for budding. This review brings together what is known on the role of various bunyavirus Gn-CTs in budding and assembly, and hypothesizes on their yet unrevealed functions in viral life cycle by comparing to the matrix proteins of NRVs.
Copyright © 2013 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23357734     DOI: 10.1016/j.virol.2013.01.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

Review 1.  Uncovering the mysteries of hantavirus infections.

Authors:  Antti Vaheri; Tomas Strandin; Jussi Hepojoki; Tarja Sironen; Heikki Henttonen; Satu Mäkelä; Jukka Mustonen
Journal:  Nat Rev Microbiol       Date:  2013-08       Impact factor: 60.633

2.  Hantavirus Gn and Gc glycoproteins self-assemble into virus-like particles.

Authors:  Rodrigo Acuña; Nicolás Cifuentes-Muñoz; Chantal L Márquez; Manuela Bulling; Jonas Klingström; Roberta Mancini; Pierre-Yves Lozach; Nicole D Tischler
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 3.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

Review 4.  The nucleocapsid protein of hantaviruses: much more than a genome-wrapping protein.

Authors:  Monika Reuter; Detlev H Krüger
Journal:  Virus Genes       Date:  2017-11-20       Impact factor: 2.332

5.  The cytosolic nucleoprotein of the plant-infecting bunyavirus tomato spotted wilt recruits endoplasmic reticulum-resident proteins to endoplasmic reticulum export sites.

Authors:  Daniela Ribeiro; Maartje Jung; Sjef Moling; Jan Willem Borst; Rob Goldbach; Richard Kormelink
Journal:  Plant Cell       Date:  2013-09-17       Impact factor: 11.277

6.  Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.

Authors:  Breanna Tercero; Krishna Narayanan; Kaori Terasaki; Shinji Makino
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

Review 7.  Hantavirus Gn and Gc envelope glycoproteins: key structural units for virus cell entry and virus assembly.

Authors:  Nicolás Cifuentes-Muñoz; Natalia Salazar-Quiroz; Nicole D Tischler
Journal:  Viruses       Date:  2014-04-21       Impact factor: 5.048

8.  High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses.

Authors:  Rajini Mudhasani; Krishna P Kota; Cary Retterer; Julie P Tran; Chris A Whitehouse; Sina Bavari
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

Review 9.  RNA Encapsidation and Packaging in the Phleboviruses.

Authors:  Katherine E Hornak; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Viruses       Date:  2016-07-15       Impact factor: 5.048

10.  Nipah Virus C Protein Recruits Tsg101 to Promote the Efficient Release of Virus in an ESCRT-Dependent Pathway.

Authors:  Arnold Park; Tatyana Yun; Frederic Vigant; Olivier Pernet; Sohui T Won; Brian E Dawes; Wojciech Bartkowski; Alexander N Freiberg; Benhur Lee
Journal:  PLoS Pathog       Date:  2016-05-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.